Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.

@article{Przybyowska2011ContributionOT,
  title={Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.},
  author={Karolina Przybyłowska and Jerzy Mrowicki and Andrzej Sygut and Piotr Gustaw Narbutt and Łukasz Dziki and Adam Dziki and Ireneusz Majsterek},
  journal={Polski przeglad chirurgiczny},
  year={2011},
  volume={83 2},
  pages={
          76-80
        }
}
UNLABELLED Inflammatory bowel disease (IBD) represents a heterogeneous group of chronic disorders characterized by inflammation of gastrointestinal tract, typically with a relapsing and remitting clinical course of unknown etiology. Presumably, IBD develops with response exogenous environmental factors only in persons with genetic predisposition. This predisposition was suggested to be associated with polymorphism and mutations in genes encoding proinflammatory immune system proteins. Enhanced… 
The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population
AbstractInflammatory bowel disease (IBD) are characterized recurrent inflammation of gastrointestinal tract. The etiology and pathogenesis this disease is currently unclear, but it has become evident
Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis
TLDR
The meta-analysis suggested that the MIF-173 G/C polymorphism contributed to the susceptibility of IBD when considering the subgroups of ethnicity and UC and CD.
Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.
TLDR
No evidence of association of MIF promoter polymorphisms with IBD is found in the New Zealand dataset, and meta-analysis of all published MIF -173G > C data from East Asian datasets found no association of this promoter polymorphism with UC.
The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis
TLDR
This meta-analysis suggests that the -173 G/C polymorphism in the macrophage MIF gene contributes to IBD susceptibility, specifically in Asian populations, and further studies are needed to validate these findings.
Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus infection in an Iranian cohort
TLDR
The results suggest that MIF ‐173 G/C variant increases the risk of HBV in Iranian subjects, and 95 bp I/D polymorphism was not associated with CP and the 185‬bp‬ I/D variant was not polymorphic in the authors' group of subjects.
The Role of MIF-173G/C Gene Polymorphism in the Susceptibility of Autoimmune Diseases
TLDR
MIF-173G/C was significantly associated with an increased risk of autoimmune diseases in five genetic models, and subgroup analysis showed an increasing risk in rheumatoid arthritis (RA), ulcerative colitis (UC), Crohn's disease (CD), atopic dermatitis (AD), Henoch-Schonlein purpura (HSP), but it was not related to the susceptibility of autoimmune hepatitis (AIH).
MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
TLDR
The known pleiotropic activities of Mif are reviewed, in addition to novel functions of MIF in processes including autophagy and autophagic cell death, which will require a comprehensive understanding of the unique and complex activities of this ubiquitously expressed cytokine.
Evaluation of MIF -173 G/C Polymorphism in Turkish Patients with Ankylosing Spondylitis.
TLDR
No significant relationship between Ankylosing spondylitis disease and MIF -173 G/C polymorphism was found and it is concluded that the time of onset and the duration of disease in AS patients is unknown.
...
1
2
...

References

SHOWING 1-10 OF 22 REFERENCES
Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis
TLDR
Data suggest that the MIF −173 G/C polymorphism may be related to the extent of disease in UC in a Japanese population.
Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases.
  • P. Renner, T. Roger, T. Calandra
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2005
TLDR
Analyses of MIF genotypes in patients with sepsis may help to classify patients into risk categories and to identify those patients who may benefit from anti-MIF therapeutic strategies.
Macrophage migration inhibitory factor (MIF) −173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease
TLDR
The MIF −173G/C polymorphism appears to be a factor contributing to a particular CD phenotype characterized by protection against upper gastrointestinal tract involvement and severe disease activity.
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
TLDR
The data suggest a cell type-specific regulation of MIF, which may be central to understanding its role in inflammation, as well as an increased risk of susceptibility to JIA.
Development of chronic colitis is dependent on the cytokine MIF
TLDR
Increased plasma MIF concentrations in patients with Crohn's disease are found, and these data suggested that MIF is a new target for intervention in Crohn’s disease.
High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints.
TLDR
The present results for the first time suggest the possibility that MIF is involved in the potentiation of inflammatory and immunological responses in rheumatoid joints.
Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
TLDR
It is concluded that anti-MIF antibodies reduce the severity of experimental colitis and limit the up-regulation of Th1-type cytokines.
Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance
TLDR
The theory that macrophage migration inhibitory factor (MIF) may have a role in the accumulation of macrophages and the pathogenesis of ulcerative colitis was studied.
...
1
2
3
...